TIS
Click for more information
0.00% 0.0¢ tissue therapies limited

Ann: Regulatory Update , page-29

  1. J8
    14,521 Posts.
    lightbulb Created with Sketch. 816
    clock Created with Sketch.
    18/03/13
    21:35
    Post #: 11554805
    Commiserations to holders .

    The real shame is that while these regulatory agencies ( who are are costing the public a fortune ) DITHER , the sick are not being healed .

    It happens consistently , products are delayed for years on end by the establishment .

    Shameful greed not careful protocol is at the heart of it .

    I
    TIS Price at posting: 15.4¢ Sentiment: None Disclosure: Not Held
    Likes Created with Sketch. 7  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Money and Investing: Talking the minefield of divorce & family law
right-arrow Created with Sketch.
IMU Imugene doses first cancer patient in Oasis trial
right-arrow Created with Sketch.
HMD HeraMED delivers digital maternity care to select clinics with Telstra
right-arrow Created with Sketch.
GWR Scoping study and Phase 2 drilling progress Prospect Ridge magnesium play for GWR
right-arrow Created with Sketch.
JGH Jade's strong gas exploration results another step towards Mongolian development
right-arrow Created with Sketch.
CTT Cettire has launched in China – but can it turn its share price around?
right-arrow Created with Sketch.
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.